PD-1 Antibody Plus Chemo Boosts Gastric Cancer Treatment
In a groundbreaking advancement for the treatment of gastric and gastroesophageal adenocarcinoma, researchers have unveiled the findings of the ROSETTE...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In a groundbreaking advancement for the treatment of gastric and gastroesophageal adenocarcinoma, researchers have unveiled the findings of the ROSETTE...
Cholesterol has long been implicated in cardiovascular diseases, but emerging research reveals its pivotal role in cancer progression, particularly colorectal...
In recent advancements within the realm of breast cancer therapy, the CompassHER2 pCR trial emerges as a beacon of hope...
A comprehensive new study has shed light on the nuanced differences in colorectal adenoma prevalence between younger and older adults,...
A novel prognostic indicator known as the platelet-neutrophil-monocyte-lymphocyte ratio (PNMLR) has recently emerged from a comprehensive study evaluating survival outcomes...
In a groundbreaking development in the treatment of rare hematologic malignancies, researchers have unveiled promising results for a novel antibody-drug...
In a groundbreaking advance poised to reshape the landscape of cancer immunotherapy, researchers have uncovered compelling evidence that specific antioxidants...
A groundbreaking study conducted by researchers at Fox Chase Cancer Center, unveiled at the prestigious American Society of Clinical Oncology’s...
In a groundbreaking advancement that could redefine therapeutic strategies against ovarian cancer, researchers have unveiled that the regulator of G-protein...
A groundbreaking study emerging from the prestigious UCLA Health Jonsson Comprehensive Cancer Center has unveiled compelling evidence that the immunotherapy...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine